TRIP10 and neoplasm: According to univariate analysis, five factors including CIP4 expression levels (HR:0.522, 95% CI:0.293–0.830, P = 0.0027), gender (HR:0.297 95% CI:0.151–0.586, P<0.001), tumor stage (HR:1.451, 95% CI:1.363–1.656, P = 0.044), lymph node status (HR:1.894, 95% CI:1.060–3.383, P = 0.031) and metastasis (HR:4.86, 95% CI:1.670–14.146, P = 0.004) exerted significant influence over survival.